Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer, thanks to a team of researchers lead by principal investigator Dr. Vered Stearns and co-principal investigator Dr. Tessa Cigler, both in the division of Hematology and Medical Oncology.
The grant will enable Weill Cornell Medicine...
